Overview of Systemic Pharmacotherapeutics of the Integumentary System
- Systemic Pharmacotherapeutics of the Integumentary System
- Overview of Systemic Pharmacotherapeutics of the Integumentary System
- Antibacterials for Integumentary Disease
- Antifungals for Integumentary Disease
- Antiparasitics for Integumentary Disease
- Antihistamines for Integumentary Disease
- Essential Fatty Acids for Integumentary Disease
- Hormonal Therapy for Integumentary Disease
- Immunomodulators for Integumentary Disease
- Psychotropic Agents for Integumentary Disease
- Vitamins and Minerals for Integumentary Disease
Also see Principles of Topical Therapy.
Drugs that may be used in the integumentary system fall into several therapeutic categories: antimicrobials (antibacterials, antifungals), antiparasitics, NSAIDs, immunomodulators, hormones, psychotropic agents, and vitamin and mineral supplements.
Several factors may contribute to the development of the particular clinical presentation. Each factor should be identified and treated for therapy to succeed. For example, recurrent otitis may have a primary underlying skin disease but be complicated by both predisposing and perpetuating factors. Further, successful treatment of skin disease may require longterm or lifelong therapy and is frequently a matter of successful control rather than “cure.”
- Systemic Pharmacotherapeutics of the Integumentary System
- Overview of Systemic Pharmacotherapeutics of the Integumentary System
- Antibacterials for Integumentary Disease
- Antifungals for Integumentary Disease
- Antiparasitics for Integumentary Disease
- Antihistamines for Integumentary Disease
- Essential Fatty Acids for Integumentary Disease
- Hormonal Therapy for Integumentary Disease
- Immunomodulators for Integumentary Disease
- Psychotropic Agents for Integumentary Disease
- Vitamins and Minerals for Integumentary Disease
Also of Interest
Test your knowledge
Dogs and cats with left-side congestive heart failure (CHF) can develop respiratory distress due to pulmonary edema. Which of the following intravenous diuretics is the most appropriate treatment for life-threatening pulmonary edema caused by CHF?